Catalyst Wire Dossier Catalyst Wire Dossier

PRT064445

PRT064445 · Portola Pharmaceuticals
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PRT064445, covering 2018-08-10 to 2018-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 2 of 4) [Phase 2]

See pricing